Arsenic inhibition of telomerase transcription leads to genetic instability

Journal of Clinical Investigation

Volumn 108, Issue 10, 2001, Pages 1541-1547

  Chou, Wen Chien ^a   Hawkins, Anita L ^a   Barrett, John F ^a   Griffin, Constance A ^a,b   Dang, Chi V ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; MESSENGER RNA; MYC PROTEIN; TELOMERASE; TRANSCRIPTION FACTOR SP1;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0035187009     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI14064     Document Type: Article

References (37)

1. Carcinogenicity, teratogenicity and mutagenicity of arsenic
2. Synergism between occupational arsenic exposure and smoking in the induction of lung cancer
3. Inorganic arsenic: A need and an opportunity to improve risk assessment
4. Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylted arsenic metabolites
5. 3 exerts dose-dependent dual effects on APL cells
6. 3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients
7. Arsenic trioxide as an inducer of apopcosis and loss of PML/RARα protein in acute promyelocytic leukemia cells
8. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
9. Acute promyelocytic leukemia
10. Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL group
11. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis
12. Rac1 regulates stress-induced, redox-dependent heat shock factor activation
13. Mutagenicity of arsenic in mammalian cells: Roles of reactive oxygen species
14. Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity
15. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
16. PIC-1/SUMO-1-modified PML-retinoic acid receptor α mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia
17. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
18. Telomere length regulation
19. Specific association of human telomerase activity with immortal cells and cancer
20. Telomere elongation in immortal human cells without detectable telomerase activity
21. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
22. Inhibition of telomerase limits the growth of human cancer cells
23. Longevity, stress response, and cancer in aging telomerase-deficient mice
24. Telomere dysfunction increases mutation rate and genomic instability
25. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic change
26. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
27. Sp1 cooperate with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
28. Direct activation of TERT transcription by c-MYC
29. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
30. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif
31. Sp1 is phosphrylated and its DNA binding activity down-regulated upon terminal differentiation of the liver
32. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT)
33. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
34. The DNA-binding efficiency of Sp1 is affected by redox changes
35. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins
36. Δ2/3 cancer-prone mouse
37. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis